These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 35874675)

  • 41. Identification of tumor-antigen signatures and immune subtypes for messenger RNA vaccine selection in advanced clear cell renal cell carcinoma.
    Xu Z; Wu Y; Chen X; Jin B
    Surgery; 2024 Sep; 176(3):785-797. PubMed ID: 38851900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically 'Cold' KIRC Tumours.
    Zhang S; Xia K; Chang Y; Wei Y; Xiong Y; Tang F; Peng J; Ouyang Y
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.
    Zhu X; Xie X; Zhao Q; Zhang L; Li C; Zhao D
    Biomed Res Int; 2020; 2020():4673153. PubMed ID: 32685487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 46. Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development.
    Fu J; Chen F; Lin Y; Gao J; Chen A; Yang J
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4047-4061. PubMed ID: 36038676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
    Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
    BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma.
    Liao Z; Xie Z
    Clin Transl Oncol; 2024 Sep; 26(9):2309-2322. PubMed ID: 38587603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.
    Zheng Q; Yang Q; Zhou J; Gu X; Zhou H; Dong X; Zhu H; Chen Z
    Cancer Cell Int; 2021 Jun; 21(1):330. PubMed ID: 34193146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration.
    Su Z; Shu K; Li G
    Cancer Biomark; 2022; 35(2):155-165. PubMed ID: 35912732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma.
    He Z; Yang H; Chen Q; Chen YP; Qin H; He W; Chen Z
    J Gastrointest Oncol; 2024 Jun; 15(3):890-907. PubMed ID: 38989426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
    Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
    Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma.
    Hu J; Yuan Z; Jiang Y; Mo Z
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.
    Zhang K; Wang J; Zhu Y; Liu X; Li J; Shi Z; Cao M; Li Y
    Front Oncol; 2022; 12():844990. PubMed ID: 35686089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
    Yang Y; Gao Y; Liu XS; Huang ZM; Zhang Y; Zhang YH; Liu ZY; Chen YX; Pei ZJ
    Exp Ther Med; 2024 Aug; 28(2):305. PubMed ID: 38873045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Prognostic Signature Constructed by
    Han S; Zhu W; Yang W; Guan Q; Chen C; He Q; Zhong Z; Zhao R; Xiong H; Han H; Li Y; Sun Z; Hu X; Tian J
    Front Genet; 2021; 12():646818. PubMed ID: 34512711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
    Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
    Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
    Liu Q; Zhang W; Wu Z; Liu H; Hu H; Shi H; Li S; Zhang X
    J Cell Biochem; 2020 Feb; 121(2):1317-1331. PubMed ID: 31486138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development a m
    Shi G; Li Y; Gao H; Wei Y; Wang Y
    Aging (Albany NY); 2023 Mar; 15(6):1944-1963. PubMed ID: 37019148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.